This week, it's time to look back at the past month in pharma, examining the industry response to coronavirus, potential blockbuster drugs of 2020 and some innovative disease awareness campaigns that score high on creativity.

Spencer is joined by the Executive Chairman of Brandon Medical, Graeme Hall, who reveals how the medical device industry is evolving and deconstructs the impact of 4K and smart operating theatres on the surgical process.

Sen is joined by a special guest on this week's podcast: Claudia Adreani, Business Head of Customer Excellence at Boehringer Ingelheim. Amongst a plethora of topics, they discuss the evolving world of marketing in pharma and Claudia's gymnastics pedigree!

Spencer is joined by eyeforpharma Chairman Paul Simms to discuss the upcoming eyeforpharma Barcelona 2020 event, as well as the importance of pharma finding and communicating their purpose to the public.

The new year has seen the pharma industry's involvement in a number of issues of global significance. And this week, Sen takes us through initiatives pharma companies have begun in January to combat the coronavirus outbreak and climate change.

Sen chats to James, co-founder of social media consultancy, Social Tree Global. They discuss the SMIP event he hosted in November and explore why pharma should overcome their social media fears to create meaningful relationships with HCPs and patients.

Isabel is joined again by Michaila to discuss her recent GOLD article, 'Marketing Forecast: Cloudy with a Chance of AI', which looks at the potential of AI to help pharma marketers streamline budgets and target with better accuracy...

Spencer is joined by Kris Sterkens, Company Group Chairman (Europe, Middle East and Africa) of Janssen and they discuss a range of topics including the evolving sales landscape, learning from tech start-ups and patient-centric drug development.

Sen casts some predictions for the coming year, looking at how the industry may respond to the rise of medicinal cannabis, as well as patient demand for easier access to clinical trials.

Sen reflects on the year 2019 and all the exciting news, challenges and trends that have been taking place in the pharmaceutical industry.